Literature DB >> 11095263

Prescription of drugs during pregnancy in France.

I Lacroix, C Damase-Michel, M Lapeyre-Mestre, J L Montastruc.   

Abstract

A survey of the records of the French Health Insurance Service of drug prescriptions during pregnancy in 1000 women living in Haute-Garonne, southwest France, showed that 99% of the women received a prescription for at least one drug during pregnancy with a mean of 13.6 medications per woman. 1.6% of women received one or more prescriptions of drugs from the US Food and Drug Administration X category (fetal risk outweighs benefits). 59% of women had a prescription of drugs from the D category (fetal risk but benefits may be acceptable) and 79% of women were exposed to drugs for which information about safety in pregnancy was not available from animal or human studies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11095263     DOI: 10.1016/s0140-6736(00)03209-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  53 in total

Review 1.  Clinical trials during pregnancy: what has been done.

Authors:  Viviana Domínguez; Nuria Ramos; Abiguei Torrents; David García; Xavier Carné
Journal:  Eur J Clin Pharmacol       Date:  2011-11-11       Impact factor: 2.953

2.  Drugs dispensed in primary care during pregnancy: a record-linkage analysis in Tayside, Scotland.

Authors:  Linda Irvine; Robert W V Flynn; Gillian Libby; Iain K Crombie; Josie M M Evans
Journal:  Drug Saf       Date:  2010-07-01       Impact factor: 5.606

3.  Incidence of Adverse Drug Reactions in High-Risk Pregnancy: A Prospective Cohort Study in Obstetric Intensive Care.

Authors:  Tatiana Xavier da Costa; Marta Danielle de Almeida Pimenta Cunha; Priscilla Karilline do Vale Bezerra; Francine Johansson Azeredo; Rand Randall Martins; Antonio Gouveia Oliveira
Journal:  Eur J Clin Pharmacol       Date:  2019-11-25       Impact factor: 2.953

4.  Herbal medicines used during the first trimester and major congenital malformations: an analysis of data from a pregnancy cohort study.

Authors:  Chao-Hua Chuang; Pat Doyle; Jung-Der Wang; Pei-Jen Chang; Jung-Nien Lai; Pau-Chung Chen
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

5.  Clinical research enrolling pregnant women: a workshop summary.

Authors:  Mary A Foulkes; Christine Grady; Catherine Y Spong; Angela Bates; Janine A Clayton
Journal:  J Womens Health (Larchmt)       Date:  2011-08-05       Impact factor: 2.681

6.  Drug exposure during the periconceptional period: a study of 1793 women.

Authors:  Elisabeth Autret-Leca; Jean Deligne; Joffray Leve; Agnès Caille; Hawaré Cissoko; Annie Pierre Jonville-Bera
Journal:  Paediatr Drugs       Date:  2011-10-01       Impact factor: 3.022

7.  Drugs in pregnancy: Implications for a cardiologist.

Authors:  Karel Rakusan
Journal:  Exp Clin Cardiol       Date:  2010

Review 8.  Maternal-fetal transport of hypoglycaemic drugs.

Authors:  Facundo Garcia-Bournissen; Denice S Feig; Gideon Koren
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

9.  Drug prescription in pregnancy: analysis of a large statutory sickness fund population.

Authors:  Veronika Egen-Lappe; Joerg Hasford
Journal:  Eur J Clin Pharmacol       Date:  2004-10-07       Impact factor: 2.953

10.  Risk management strategies in the Physicians' Desk Reference product labels for pregnancy category X drugs.

Authors:  Kathleen Uhl; Dianne L Kennedy; Sandra L Kweder
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.